Teriflunomide Tablet, Film Coated
Product Images NDC 70710-1114

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 70710-1114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriflunomide Tablets (52364a7a Fc8b 4d35 B24c 57f9cc367449 01)

Chemical structure of teriflunomide, an active ingredient shown as a molecular diagram with aromatic rings, cyano, trifluoromethyl, amide, and hydroxyl functional groups.*

FDA Label Image

Teriflunomide Tablets (52364a7a Fc8b 4d35 B24c 57f9cc367449 02)

A line graph depicting disability progression sustained over 12 weeks (%) across weeks up to 108 for placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide. The graph includes data on the number of patients at risk over time for each group. The lines show increasing disability progression with placebo reaching about 27.3%, 7 mg Teriflunomide about 21.7%, and 14 mg Teriflunomide about 20.2%, with a noted statistically significant difference (p<0.05) comparing 14 mg Teriflunomide to placebo.*

FDA Label Image

Teriflunomide Tablets (52364a7a Fc8b 4d35 B24c 57f9cc367449 03)

A line graph showing disability progression sustained for 12 weeks over time in weeks for placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The vertical axis represents the percentage of disability progression, and the horizontal axis represents weeks up to 108. The graph includes a table indicating the number at risk for each group at various time points. A note indicates statistical significance for 14 mg Teriflunomide versus placebo (p<0.05).*

FDA Label Image

Teriflunomide Tablets (52364a7a Fc8b 4d35 B24c 57f9cc367449 04)

Label for Teriflunomide Tablets, USP 7 mg oral film-coated tablets. The package contains 30 tablets and is labeled for prescription use only. The label includes the NDC 70710-1114-3, manufacturer Zydus Lifesciences Ltd., and distributor Zydus Pharmaceuticals USA Inc. Storage information and dosing instructions are also shown.*

FDA Label Image

Teriflunomide Tablets (52364a7a Fc8b 4d35 B24c 57f9cc367449 05)

Label for Teriflunomide Tablets, USP 14 mg film-coated tablets, oral use, by Zydus Pharmaceuticals USA Inc. The package contains 30 tablets. The label includes dosage instructions, child-resistant packaging notice, storage conditions, and manufacturer and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.